A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer
Clinical trial NCT04071262 · COMPLETED
Trial details
- NCT number
- NCT04071262
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-20
- Primary completion
- 2021-02-12
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.